OVAT.CN - Ovation Science Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.2850
-0.0250 (-8.06%)
As of 2:33PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.3100
Open0.2850
Bid0.2850 x 0
Ask0.3050 x 0
Day's Range0.2850 - 0.2850
52 Week Range0.2500 - 0.6500
Volume700
Avg. Volume11,944
Market Cap6.606M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0340
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Ovation Science Remains #1 With Its Patented Topical Cannabis Products

    According to Headset data, a cannabis analytics company that provides key business intelligence to the cannabis industry, Ovation Science's transdermal CBD (cannabidiol) formulation under license again is ranked the #1 selling topical in Nevada in June by number of units sold according to their latest update.

  • CNW Group

    Ovation Science Announces the Completed Development of Its Second CBD Infused Product Line Focused on Health and Wellness

    VANCOUVER, May 21, 2019 /CNW/ - Ovation Science Inc. (CSE: OVAT) ("Ovation" or the "Company"), a product development company with a patented skin delivery technology and twenty-plus years of skincare research and development, today announced the completion of its second cannabidiol ("CBD") product line Invibe MD.  Invibe MD is a "health and wellness" product line infused with hemp-derived CBD and delivered by Ovation's patented skin delivery technology. This new product line follows our recent announcement regarding the Company's anti-aging skincare product line ARLO CBD Beauty.

  • CNW Group

    Ovation Science Product Achieves #1 in Nevada

    VANCOUVER, May 7, 2019 /CNW/ - Ovation Science Inc. (CSE: OVAT) ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and development, is pleased to announce that one of Ovation's proprietary products, marketed by Ovation's US licensee, was the top selling product in Nevada dispensaries in April according to HeadSet Inc., an analytics service provider for the cannabis industry. "We know our topical and transdermal cannabis products work exceptionally well because we have the consumer testimonials that tell us this every day," said Terry Howlett, CEO of Ovation. "In addition, we are extremely proud that our licensed product achieved the highest unit sales in April in dispensaries in Nevada."  He added, "Our US licensee markets our products to the dispensary market under their brand name BASKiN, and have introduced four Ovation products within the last year.

  • ACCESSWIRE

    The Top Cannabis Beauty Products Just Hitting the Retail Market

    HOUSTON, TX / ACCESSWIRE / April 30, 2019 / The cannabis beauty market is just beginning to gain momentum. "There is a great deal of room for innovation in his sector, and topicals and beauty products are expected to explode with legalization and the entry of major consumer packaged goods companies," notes market research firm, The Brightfield Group. Some of the top companies benefiting from the news are The Yield Growth Corporation (CSE:BOSS)(OTCQB:BOSQF), Canopy Rivers Inc. (TSXV:RIV)(OTC:CNPOF), and Ovation Science Inc. (CSE:OVAT)(OTC:OVATF).

  • CNW Group

    Ovation Science's CBD Sunscreen Achieves Highest FDA Claims

    VANCOUVER, April 30, 2019 /CNW/ - Ovation Science Inc. (CSE: OVAT) ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and development, today announced it has received the results of its successful completion of independent testing of its broad spectrum CBD sunscreen to be sold under its recently announced ARLO Beauty brand of skincare and anti-aging products. There are two very important claims that a sunscreen can make: broad spectrum and water resistance.

  • CNW Group

    Ovation Science Announces the Formation of an International Medical Dermatology Advisory Board Focused on Cannabis

    VANCOUVER, April 23, 2019 /CNW/ - Ovation Science Inc. (CSE: OVAT) ("Ovation" or the "Company"), a cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and development, today announced it has entered into an exclusive agreement with Skincareguide.com Ltd., a leading international peer-reviewed publisher and an authoritative source of dermatology information for physicians and consumers since 2001, to act as the Company's Medical Dermatology Advisory Board for cannabis formulated products. With the Company's Medical Dermatology Advisory Board in place, Ovation will be able to consider dermatology-focused product line expansion following the previous announcement of its anti-aging product line ARLO Beauty.

  • CNW Group

    Ovation Science Announces Launch of CBD Infused Skincare Product Line as Global Opportunities Become Available

    VANCOUVER, April 16, 2019 /CNW/ - Ovation Science Inc. (CSE: OVAT) ("Ovation" or the "Company"), a product development company with a patented skin delivery technology and backed by over twenty years of research and development, today unveiled the launch of its new topical skincare product line infused with hemp-derived cannabidiol ("CBD") called ARLO Beauty. This announcement is in conjunction with the announcement that Ovation and Canopy Growth Partners have mutually elected to terminate their license agreement, eliminating the restrictions preventing the Company from dealing with other licensed producers in Canada and terminating the rights of first refusal held by Canopy which inhibited Ovation's ability to roll out its own line of non dispensary products in the US and both dispensary and non dispensary products in other countries.

  • CNW Group

    Ovation Science Creates New Cannabis Product Category That You Don't Have to Smoke

    VANCOUVER, Feb. 19, 2019 /CNW/ - Ovation Science Inc. (CSE: OVAT) ("Ovation" or the "Company"), with the goal to be the leader in the topical and transdermal cannabis market by leveraging its patented skin delivery technology and its twenty-plus years of skincare research and development, in conjunction with Cannabiniers, a global cannabis brand management company, today unveiled the creation of a new product category for the cannabis market: recreational transdermal creams. This first-to-market recreational cannabis product has been formulated to quickly deliver a high-dose of THC into the blood stream (transdermal). BASKiN GLOW contains 500 milligrams of THC and 50 milligrams of CBD in each 59ml jar.

  • Recent US and Canadian Cannabis Developments Have Potential for a Positive Impact on Ovation's Business
    CNW Group

    Recent US and Canadian Cannabis Developments Have Potential for a Positive Impact on Ovation's Business

    On December 20, 2018 the 2018 Farm Bill became law in the United States. Under the 2018 Farm Bill, industrial and commercial hemp will no longer be classified as a Schedule I controlled substance in the United States.

  • Ovation Science's Licensee Debuts Third CBD Product in US Market
    CNW Group

    Ovation Science's Licensee Debuts Third CBD Product in US Market

    Fitness Enthusiasts to Benefit with Pre and Post Work-Out Cream VANCOUVER , Dec. 6, 2018 /CNW/ -  Ovation Science Inc. (CSE: OVAT ) ("Ovation" or the "Company"), a skincare research ...

  • Newsfile

    CSE New Listing - Ovation Science Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

    Vancouver, British Columbia--(Newsfile Corp. - November 19, 2018) -  Ovation Science (CSE: OVAT) is one of the latest new listing on the Canadian Securities Exchange. On September 29, 2017, the company entered into a licensing and assignment agreement with Skinvisible, under which Ovation acquired the exclusive worldwide right to manufacture, distribute, market, sell, sublicense and promote products formulated with Invisicare® technology for hemp seed oil and cannabis products. In consideration, Ovation paid US$500,000 to ...